alopecia areata
play

Alopecia areata Lidia Rudnicka Department of Dermatology, Medical University of Warsaw Poland lidiarudnicka@gmail.com I have no relevant conflicts of interest anagen phase Hair cycle telogen phase catagen phase anagen effluvium Anagen

0 downloads 2 Views 3,65 MB Size Report
  1. Alopecia areata Lidia Rudnicka Department of Dermatology, Medical University of Warsaw Poland lidiarudnicka@gmail.com I have no relevant conflicts of interest

  2. anagen phase Hair cycle telogen phase catagen phase

  3. anagen effluvium Anagen effluvium occurs after any insult to the hair follicle that impairs its mitotic activity . Causes: Inflammatory (alopecia areata) Drug-induced (chemotherapy, retinoids) Toxic (thallium, arsenic) Extreme nutrient deficiencies

  4. High mitotic activity - thick hair Low mitotic activity - thin hair No mitotic activity - no hair

  5. • Common trichoscopy features of AA • Rare trichoscopy features of AA • Trichoscopic cases in AA

  6. Alopecia areata in trichoscopy Exclamation mark hairs Black dots Yellow dots

  7. Multiple exclamation mark hairs = high disease activity

  8. Alopecia areata – tapered hairs Tapered hairs are elongated exclamation mark hairs Inui et al. 2009

  9. Pohl-Pinkus constrictions and monilethrix-like hairs in alopecia areata These hairs differ from true monilethrix by the irregular distribution of constrictions

  10. Alopecia areata – black dots

  11. black dots a marker of high disease activity in alopecia areata but not specific for alopecia areata

  12. Alopecia areata – yellow dots

  13. Yellow dots may not be visible in Asian patients S. Inui . Trichoscopy in Asian Skin in Atlas of Trichoscopy, 2012

  14. • Common trichoscopy features of AA • Rare trichoscopy features of AA • Trichoscopic cases in AA

  15. Alopecia areata – vellus hairs Asian Caucasian Marker of disease severity ? Inui et al

  16. • Trichorrhexis nodosa • Zigzag hairs

  17. Zigzag hairs

  18. Alopecia areata – regrowing hairs 70x circle pigtail

  19. Trichoscopy feature % of patients with AA Yellow dots 63-94% Black dots 44-70% Exclamation mark hairs 30-44% Tapered hairs 12-42% Broken hairs 45-58% Vellus hairs 33-72% Trichorrhexis nodosa 3-16% Monilethrix-like hairs 2-3% Pohl-Pinkus constrictions Regrowing hairs Source: Atlas of Trichoscopy, 2012

  20. • Common trichoscopy features of AA • Rare trichoscopy features of AA • Trichoscopic cases in AA

  21. 43 – year old woman Chemotherapy – induced alopecia

Recommend Documents


jak inhibitor ctp 543 achieves primary endpoint in phase
JAK Inhibitor CTP-543 Achieves Primary

American Academy of Dermatology Annual Meeting March 2, 2019 JAK Inhibitor

ctp 543 phase 2 results in patients with moderate to
CTP-543 Phase 2 Results in Patients

CTP-543 Phase 2 Results in Patients with Moderate-to-Severe Alopecia Areata

salt 20 was statistically significant from placebo for
SALT 20 was statistically significant

Abstract: American Academy of Dermatology Annual Meeting 2020 New CTP-543

frontal fibrosing alopecia
FRONTAL FIBROSING ALOPECIA Lidia

FRONTAL FIBROSING ALOPECIA Lidia Rudnicka Department of Dermatology, Medical

australian implementation
Australian Implementation of scalp

Australian Implementation of scalp cooling for prevention of chemotherapy

outline
Outline Care Practitioner Urticaria

Dermatology Pearls for the Primary Outline Care Practitioner Urticaria

outline
Outline Care Practitioner Urticaria

4/5/18 Dermatology Pearls for the Primary Outline Care Practitioner

various factors causing hair loss apart from androgenic
Various Factors causing Hair loss apart

Various Factors causing Hair loss apart from Androgenic Alopecia External

ctp 543 an oral jak inhibitor achieves primary endpoint
CTP-543, an Oral JAK Inhibitor,

European Academy of Dermatology and Venereology Annual Congress October 12,

outline
Outline Care Practitioner Part 1

Dermatology Pearls for the Primary Outline Care Practitioner Part 1

the basis of evidence transfer and persistence
The Basis of Evidence: Transfer and

The Basis of Evidence: Transfer and Persistence Developed by Edmund Locard, a

chf cardiac transplant consultation
CHF / Cardiac Transplant Consultation

CHF / Cardiac Transplant Consultation Wooster Community Hospital September,

visible services amp transport waste management amp
Visible Services & Transport Waste

Visible Services & Transport Waste Management & Cleansing Waste

progress update presentation
Progress Update Presentation AGM

Progress Update Presentation AGM November 2017 Presentations Overview:

a discussion on alternative renewable fuels and advanced
A Discussion on Alternative Renewable

A Discussion on Alternative Renewable Fuels and Advanced Vehicle Technology

resistance strength training cardiovascular training but
Resistance/strength training

Resistance/strength training Cardiovascular training But was that really the

where we are today
Where We Are Today April 3, 2020 New

Where We Are Today April 3, 2020 New and Cumulative COVID-19 Cases and

infinity
INFINITY AT HOME E DUCATION SE MIN AR

INFINITY AT HOME E DUCATION SE MIN AR HAIR REMOVAL HOW IT ALL BEGAN. + =

pulsed light hair removal
PULSED LIGHT HAIR REMOVAL A fast,

Palomar PULSED LIGHT HAIR REMOVAL A fast, comfortable and permanent

where we are today
Where We Are Today April 8, 2020 New

Where We Are Today April 8, 2020 New and Cumulative COVID-19 Cases and

corneal reconstruction using tissue engineered epithelial
Corneal Reconstruction Using Tissue-

Corneal Reconstruction Using Tissue- Engineered Epithelial Cell Sheets

full scale exercises
Full Scale Exercises An overview for

Full Scale Exercises An overview for the Safeguard Iowa Partnership Using